Continuous exercise may immediately lower glucose levels regardless of Menstrual Cycle Phase, finds study Dr Riya Dave21 Jun 2025 9:30 AM ISTResearchers have found in a new study Continuous exercise (CONT) immediately lowers glucose levels regardless of the menstrual phase. However, time in...
Chronic Hepatitis B May Raise Risk of Pre-eclampsia and Eclampsia, Genetic Study Finds Medha Baranwal21 Jun 2025 9:15 AM ISTChina: A recent study published in the Journal of Obstetrics and Gynaecology has found compelling genetic evidence suggesting that chronic hepatitis B...
Frailty Significantly Increases Mortality and Complications in PCI Patients, NCDR Registry Study Finds Medha Baranwal21 Jun 2025 8:00 AM ISTUSA: Frailty is common among older patients undergoing percutaneous coronary intervention (PCI) in the United States, with greater frailty linked to...
Enlicitide Decanoate Promising as Oral PCSK9 Inhibitor in Hyperlipidemia in Phase 3 trials Dr. Kamal Kant Kohli21 Jun 2025 7:30 AM ISTPhase 3 trials have demonstrated that enlicitide decanoate significantly reduces LDL cholesterol, showing strong potential as an oral PCSK9 inhibitor...
Digital Inhalers Improve Asthma Control, May Lower Risk of Severe Exacerbations: Study Shows Medha Baranwal20 Jun 2025 10:00 PM ISTCanada: A comprehensive meta-analysis has found that patient-facing digital inhalers may significantly improve asthma management, particularly among...
Vitiligo Linked to Increased Risk of Heart, Autoimmune, and Mental Health Conditions: Study Shows Medha Baranwal20 Jun 2025 9:30 PM ISTUSA: In a recent case-control study utilizing data from the All of Us research program, researchers have uncovered a broad spectrum of comorbidities...
Vitamin D increases likelihood that breast cancer will disappear with chemotherapy: Study Dr. Kamal Kant Kohli20 Jun 2025 9:15 PM ISTA study conducted at the Botucatu School of Medicine at Sao Paulo State University (FMB-UNESP) in Brazil has shown that low-dose vitamin D...
FDA Approves Clesrovimab to Prevent RSV in Infants Dr. Kamal Kant Kohli20 Jun 2025 9:00 PM ISTThe FDA has approved clesrovimab, marketed as Enflonsia, for the prevention of RSV lower respiratory tract disease in neonates and infants during...
Phentolamine Eye Drops Improve Night Driving Post-Refractive Surgery in Phase 3 trial Dr. Kamal Kant Kohli20 Jun 2025 9:00 PM ISTResearchers have found in a phase 3 trial that phentolamine ophthalmic solution 0.75% led to significant improvements in mesopic low contrast distance...
Machine learning model helps identify patients at risk of postpartum depression Dr. Kamal Kant Kohli20 Jun 2025 8:30 PM ISTPostpartum depression (PPD) affects up to 15 percent of individuals after childbirth. Early identification of patients at risk of PPD could improve...
Fatty liver-but not liver damage-common in type 2 diabetes, suggests study Dr. Kamal Kant Kohli20 Jun 2025 9:30 AM ISTSix out of ten people with type 2 diabetes had fatty liver in a new study from Linköping University. Of these, only a small percentage had developed...
Experimental Obesity Drug Eloralintide Shows Over 11% Weight Loss in Phase I Trial Dr. Kamal Kant Kohli20 Jun 2025 9:00 AM ISTIt has been found in a phase I study that patients taking Eli Lilly's investigational obesity drug eloralintide lost more than 11% of their body...
